{"id":"W2170362988","doi":"10.1093/annonc/mdl316","title":"A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University; University Health Network; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Mantle cell lymphoma; Bortezomib; Discontinuation; Internal medicine; Adverse effect; Toxicity; Clinical trial; Surgery; Lymphoma; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00265941,0.0001275827,0.001183575,0.000107399,0.00004166106,0.000001688934,0.0001229232,0.0001278456,0.00006618423],"category_scores_gemma":[0.0005568046,0.00008214933,0.0001795232,0.0002043676,0.0001437921,0.00003765244,0.00005353933,0.00006987622,4.490552e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002001546,"about_ca_system_score_gemma":0.0035808,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3506123,"about_ca_topic_score_gemma":0.4818456,"domain_scores_codex":[0.9969891,0.0004907407,0.00169265,0.0002127951,0.0004230546,0.0001916953],"domain_scores_gemma":[0.9975718,0.001036402,0.000878169,0.0001739047,0.0002780226,0.00006168616],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1261713,0.4039244,0.1151319,0.000152617,0.001939382,0.0005072228,0.001156292,0.000170538,0.0009343156,0.001891597,0.1958363,0.1521841],"study_design_scores_gemma":[0.6430099,0.05390402,0.214845,0.00008096424,0.0005166858,0.00001092803,0.0004551184,0.00005663473,0.005065845,0.0003044916,0.08159461,0.0001557644],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914647,0.0005512808,5.532982e-7,0.002440203,0.0006344119,0.001313659,0.0001147254,0.000002875316,0.003477593],"genre_scores_gemma":[0.9984683,0.0002080597,0.00002534758,0.0005884864,0.0003641147,0.0001846797,0.0000252825,0.000007245099,0.0001284992],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5168387,"threshold_uncertainty_score":0.6537121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2385970567865029,"score_gpt":0.5021967957604048,"score_spread":0.2635997389739019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}